Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children

Intensive Care Medicine

Volumn 33, Issue 6, 2007, Pages 1025-1032

  Pavcnik Arnol, Maja ^a   Hojker, Sergej ^a   Derganc, Metka ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Lipopolysaccharide; Lipopolysaccharide binding protein; Neonates; Sepsis; Soluble CD14; Systemic inflammatory response syndrome

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD14 ANTIGEN; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; PROCALCITONIN;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; HEMOCONCENTRATION; HUMAN; INFANT; INFECTION; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INTENSIVE CARE; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ACUTE-PHASE PROTEINS; ADOLESCENT; ANTIGENS, CD14; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; HUMANS; INFANT, NEWBORN; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; PROSPECTIVE STUDIES; SLOVENIA; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 34249683661     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0626-y     Document Type: Article

References (39)

1. Proulx F, Fayon M, Farrell C, Lacroix J, Gauthier M (1996) Epidemiology of sepsis and multiple dysfunction syndrome in children. Chest 109:1033-1037
2. Turner D, Hammerman C, Rudensky B, Schlesinger Y, Goia C, Schimmel MS (2006) Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch Dis Child Fetal Neonatal Ed 91:F283-F286
3. Bonac B, Derganc M, Wraber B, Hojker S (2000) Interleukin-8 and procalcitonin in early diagnosis of early severe bacterial infection in critically ill neonates. Pflugers Arch [Suppl 5]440:R72-R74
4. Blommendahl J, Janas M, Laine S, Miettinen A, Ashorn P (2002) Comparison of procalcitonin with CRP and differential white blood cell count for diagnosis of culture-proven neonatal sepsis. Scand J Infect Dis 34:620-622
5. Pavcnik-Arnol M, Hojker S, Derganc M (2004) Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein. Intensive Care Med 30:1454-1460
6. Lopez Sastre JB, Perez Solis D, Roques Serradilla V, Fernandez Colomer B, Coto Cotallo GD, Vidal XK, Narabona Lopez E, Garcia del Rio M, Sanchez Luna M, Belaustegui Cueto A, Moro Serrano M, Urbon Artero A, Alvaro Iglesias E, Cotero Lavin A, Martinez Vilalta E, Jimenez Cobos B, Grupo de Hospitales Castrillo (2006) Procalcitonin is not sufficiently reliable to be the sole marker of neonatal sepsis of nosocomial origin. BMC Pediatrics 6:16-22
7. Casado-Flores J, Blanco-Quiros A, Asensio J, Arranz E, Garrote JA, Nieto M (2003) Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count. Ped Crit Care Med 4:190-195
8. Arkader R, Troster EJ, Lopes MR, Junior RR, Carcillo JA, Leone C, Okay TS (2006) Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome. Arch Dis Child 91:117-120
9. Zweigner J, Schumann RR, Weber JR (2006) The role of lipopolysaccharide- binding protein in modulating the innate immune response. Microb Infect 8:946-952
10. Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, Parejo NA, Pribble JP, Lemke JH (1999) Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 180:1584-1589
11. Blairon L, Wittebole X, Laterre PF (2003) Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections. J Infect Dis 187:287-291
12. Berner R, Furll B, Stelter F, Drose J, Muller HP, Schutt C (2002) Elevated levels of lipopolysaccharide-binding protein and soluble CD14 in plasma in neonatal early-onset sepsis. Clin Diagn Lab Immunol 9:440-445
13. Behrendt D, Dembinski J, Heep A, Bartman P (2004) Lipopolysaccharide binding protein in preterm infants. Arch Dis Child Fetal Neonatal Ed 89:F551-F554
14. Orlikowsky TW, Trug C, Neunhoeffer F, Deperschmidt M, Eichner M, Poets CF (2006) Lipopolysaccharide-binding protein in noninfected neonates and those with suspected early-onset bacterial infection. J Perinatol 26:115-119
15. Triantafilou M, Triantafilou K (2005) The dynamics of LPS recognition: complex orchestration of multiple receptors. J Endotoxin Res 11:5-11
16. Scheifele DW, Melton P, Whitchelo V (1981) Evaluation of the Limulus test for endotoxemia in neonates with suspected sepsis. J Pediatr 98:899-903
17. Blanco A, Solis G, Arranz E, Coto GD, Ramos A, Telleria (1996) Serum levels of CD14 in neonatal sepsis by Gram-positive and Gram-negative bacteria. Acta Paediatr 85:728-732
18. Pavcnik-Arnol M, Hojker S, Derganc M (2006) Lipopolysaccharide-binding protein in critically ill children with suspected infection: comparison with lipopolysaccharide, soluble CD14, procalcitonin, and C-reactive protein. In: Book of abstracts of European Academy of Paediatrics; 2006 Oct 7-10, Barcelona. Barcelona: Kenes, p 62
19. Goldstein B, Giroir B, Randolph A, the Members of the International Consensus Conference on Pediatric Sepsis (2005) International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2-8
20. Pollack MM, Patel KM, Ruttimann UE (1996) PRISM III: An updated Pediatric Risk of Mortality score. Crit Care Med 24:743-752
21. Tobias PS, Soldau K, Ulevitch RJ (1986) Isolation of a lipopolysaccharide-binding acute-phase reactant from rabbit serum. J Exp Med 164:777-793
22. Prucha M, Herold I, Zazula R, Dubska L, Dostal M, Hildebrand T, Hyanek J (2003) Significance of lipopolysaccharide-binding protein (an acute phase protein) in monitoring critically ill patients. Crit Care 7:R154-R159
23. Gaini S, Koldkjaer OG, Pedersen C, Pedersen SS (2006) Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study. Crit Care 10:R53-R62
24. Myc A, Buck J, Gonin J, Reynolds B, Hammerling U, Emanuel D (1997) The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome. Clin Diagn Lab Immunol 4:113-116
25. Takeshita S, Tsujimoto H, Kawase H, Kawamura Y, Sekine I (2002) Increased levels of lipopolysaccharide binding protein in plasma in children with Kawasaki disease. Clin Diagn Lab Immunol 9:205-206
26. Bortolussi R, Rajaraman K, Qing G, Rajaraman R (1997) Fibronectin enhances in vitro lipopolysaccharide priming of polymorphonuclear leukocytes. Blood 89:4182-4189
27. Yaegashi Y, Shirakawa K, Sato N, Suzuki Y, Kojika M, Imai S, Takahashi G, Miyata M, Furusako S, Endo S (2005) Evaluation of a newly identified soluble CD14 subtype as a marker of sepsis. J Infect Chemother 11:234-238
28. Cohen J (2000) The detection and interpretation of endotoxaemia. Intensive Care Med 26:S51-S56
29. Martin TR, Rubenfeld GD, Ruzinski JT, Goodman RB, Steinberg KP, Leturcq DJ, Moriarty AM, Raghu G, Baughman RP, Hudson LD (1997) Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 155:937-944
30. Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C (2004) CD14 is an acute-phase protein. J Immunol 172:4470-4479
31. Scott Watson R, Carcillo JA (2005) Scope and epidemiology of pediatric sepsis. Pediatr Crit Care Med [Suppl]6:S3-S5
32. Resch B, Gusenleitner W, Muller WD (2003) Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatr 92:243-245
33. Kitchens RL, Thompson PA (2003) Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins. J Endotoxin Res 9:113-118
34. Lequier LL, Nikaidoh H, Leonard SR, Bokovoy JL, White ML, Scannon PJ, Giroir BP (2000) Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest 117:1706-1712
35. Bolke E, Jehle PM, Trautmann M, Gotz I, Krebs B, Steinbach G, Orth K (2002) Different acute-phase response in newborns and infants undergoing surgery. Pediatr Res 51:333-338
36. Holmlund U, Hoglind A, Larsson AK, Nilsson C, Sverremark Ekstrom E (2003) CD14 and developmet of atopic disease at 2 years of age in children with atopic or non-atopic mothers. Clin Exp Allergy 33:455-463
37. Takeshita S, Nakatani K, Tsujimoto H, Kawamura Y, Kawase H, Sekine I (2000) Increased levels of circulating soluble CD14 in Kawasaki disease. Clin Exp Immunol 119:376-381
38. Carrillo EH, Gordon L, Goode E, Davis E, Polk HC (2001) Early elevation of soluble CD14 may help identify trauma patients at high risk for infection. J Trauma 50:810-816
39. Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, Opal S, Abraham E, Brett SJ, Smith T, Mehta S, Derzko A, Romaschin A (2004) Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 190:527-534